In 2026, Concerta remains a leading extended-release formulation of methylphenidate, widely prescribed for attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. This once-daily medication delivers steady symptom control over 10-12 hours by increasing dopamine and norepinephrine activity in the brain, helping improve focus, reduce impulsivity, and manage hyperactivity. Demand to buy Concerta persists […]